Xtx Topco LTD Amylyx Pharmaceuticals, Inc. Transaction History
Xtx Topco LTD
- $1.12 Billion
- Q2 2024
A detailed history of Xtx Topco LTD transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 210,612 shares of AMLX stock, worth $551,803. This represents 0.04% of its overall portfolio holdings.
Number of Shares
210,612Holding current value
$551,803% of portfolio
0.04%Shares
4 transactions
Others Institutions Holding AMLX
# of Institutions
140Shares Held
44.6MCall Options Held
226KPut Options Held
909K-
Vanguard Group Inc Valley Forge, PA4.22MShares$11.1 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT3.34MShares$8.75 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$6.99 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.61MShares$6.84 Million0.0% of portfolio
-
Almitas Capital LLC Santa Monica, CA1.9MShares$4.99 Million1.57% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $153M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...